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Introduction: An intraosseous infusion (IO) is a safe and simple method to administer ﬂuid in an emergency situation and can be used to gain rapid vascular access in a
critically ill child. Fluids and drugs can be infused as well as blood boluses, but very few cases describe the infusion of blood products.
Case Report: In this case study we report of a successful transfusion of ﬂuid and blood by IO to a 31 months old child, who had suffered severe epistaxis for 12 hours.
The child was unconscious at time of admission and the hemoglobin (Hb) level was measured to 3.6 g/dl. Through an IO in the proximal tibia, 300 ml of ﬂuid was ﬁrst
infused, followed by 200 ml of blood.
Discussion: We conclude that IO should be placed without delay when venous access is not rapidly obtained.Introduction: Une perfusion par voie intraosseuse (PI) est une me´thode suˆre et simple d’administrer un ﬂuide dans une situation d’urgence et peut eˆtre utilise´e pour
obtenir un acce`s vasculaire rapide chez un enfant gravement malade. Les fuildes et les me´dicaments peuvent eˆtre administre´s par perfusion ainsi que des bolus sanguins,
mais peu de cas de´crivent la perfusion de produits sanguins.
Rapport de cas: Dans cette e´tude de cas, nous rapportons le cas d’une transfusion re´ussie de ﬂuide et de sang par PI a` un enfant de 31 mois, qui a souffert d’une
e´pistaxis se´ve`re pendant 12 heures. L’enfant e´tait inconscient au moment de l’admission et le niveau d’he´moglobine (Hb) a e´te´ mesure´ a` 3.6 g/dl. Graˆce a` une PI dans
le tibia proximal, 300 ml de ﬂuide ont d’abord e´te´ perfuse´s, suivis de 200 ml de sang.
Discussion: Nous concluons en afﬁrmant qu’une PI doit eˆtre re´alise´e sur-le-champ lorsqu’un acce`s veineux n’est pas rapidement obtenu.African relevance
 Several conditions including bleeding, trauma and severe
anaemia due to malaria can cause circulatory shock requir-
ing both IV ﬂuids and an urgent blood transfusion.
 An 18 gauge needle, alcoholic swabs and a syringe are the
only necessary equipment which are possible to also use
in smaller hospitals.
 Establishing an intraosseous access is a technique that can
be easily taught and therefore can be widely used.Introduction
Establishing a peripheral intravenous venous access (IV) is a
common task in an emergency centre, but in paediatric pa-
tients several attempts are often required to successfully insert
the IV.1 In the circulatory unstable child the rapid placement
of a vascular access is crucial for the patient’s survival. The
intraosseous (IO) needle has been shown to be easier to place
successfully than the IV, and can therefore be an important
alternative in emergency cases.2,3 It was widely used in World
War II,4 and then re-emerged as an option for ﬂuid and drug
resuscitation in the critically ill child in the 1980’s, following
the famous editorial by JP Orlowski ‘‘My kingdom for an
intravenous line’’.5 Several different sites can be used for IO
insertion, the most common one used in children is the anter-
omedial surface of the proximal tibia. The technique of inser-
tion can easily be taught. The goal is to remove the IO needle
within 3–4 h, but as soon as an IV access is established it
should be removed. The risk of infection increases after 72–
96 h.6–8
84 E. Chansa et al.This is a case report of a 31 month old child presenting with
hypovolemic shock and anaemia due to severe epistaxis, who
received an IO blood transfusion through an 18 gauge hypo-
dermic needle.
Case report
A 2 year and 7 month old child of sub-Saharan African des-
cent was brought to Mpongwe Mission Hospital in Zambia
in an emergency condition due to epistaxis and fatigue. The
child started nose bleeding 12 h earlier, but the parents were
unable to get to the hospital due to unavailability of transport.
At time of admission the child was not actively bleeding, but
was unconscious, presenting with peripheral coldness and ex-
tremely pale skin. One of the most skilled clinical ofﬁcers at-
tempted to establish an IV access. He tried to access the
peripheral veins, vena jugularis externa and ﬁnally vena femor-
alis, but after 2–3 min the child’s heart beat was almost inau-
dible. At this moment we decided to perform an intraosseous
infusion in the tibia using an 18 gauge needle. At insertion,
we immediately entered the bone marrow. We managed to
withdraw blood for urgent haemoglobin estimation, grouping
and cross-matching from the femoral venal puncture. The
Haemoglobin level was 3.6 g/dl, the white blood count was
23.3 · 109/L and the platelet count was 178 · 109/L. Three
hundred ml of Ringers Lactate was infused during one hour,
during which the child showed signs of improvement by crying,
responding to pain and regaining peripheral warmth. After one
hour, we received blood from the laboratory and as we still
only had access to the bone marrow, we decided to transfuse
the blood through the IO. However, due to the high pressure
in the bone marrow the blood could not be rapidly infused.
Therefore, we decided to infuse directly into the bone marrow
using a syringe. After injecting a few ml of blood, the child
started bleeding from the nose again. We inserted nasal packs
soaked with adrenaline, simultaneously as one of us drew
blood from a receiver and one of us injected the blood into
the bone marrow. After approximately 90 min the child was
sitting up, drinking coke. Due to the fact that the situation
had been very urgent, completely sterile conditions were not
achieved. As a preventative measure, the child received one
dose of intraosseous antibiotics (cloxacillin). The child’s condi-
tion kept on improving throughout the day and night. There
were no signs of fever or pain from the injection site the follow-
ing day, the child had recovered well, and was discharged.
Since we estimated that the blood loss was bigger than the sup-
ply, and the child had a poor nutritional status, we prescribed
5 mg of folic acid daily for one month and 50 mg of ferrous
sulphate three times daily for one month. At the return visit
one week later, the haemoglobin level was 6.0 g/dl. Three
months later, the haemoglobin level was 9.4 g/dl and the child
was doing well.
Discussion
The bone marrow consists of a network of vessels that emp-
ties into a central vein and functions as a non-collapsible vein
during hypovolemia or shock. Any intravenous ﬂuid, blood
products or routine resuscitation drugs can be administered
through the IO route. Complications for short term use arerelatively rare compared to the advantages for a child who
needs rapid administration of blood or ﬂuid. The most com-
mon complication is extravasation of ﬂuid, but that is often
associated with too much movement during insertion, which
we avoided by holding the leg straight throughout the proce-
dure. Bone marrow and fat emboli in the venous circulation
and the lungs due to the open blood vessels in the medullary
cavity, presence of disrupted bone marrow and increased
intramedullary pressure have been described, but so far no
paediatric cases have been reported.9 One case of intravascu-
lar air after intraosseous infusion was observed in a 4-month-
old boy who died from Sudden Infant Death Syndrome
(SIDS); this complication can be avoided by ensuring that
intraosseous needles are never disconnected.10 Another rare,
but serious risk is that of compartment syndrome. This can
be minimized by using a proper technique, ensuring the nee-
dle remains in the marrow and does not pass through the
other cortex as well as only making one attempt at insertion
per bone. Extravasation of hypertonic or speciﬁc medications
can result in necrosis of the muscle. Infection and osteomyeli-
tis are rare complications but can occur if an aseptic
technique is not followed during insertion.11,12 In our case
we could not ensure complete sterility at the insertion of
the IO, which is why we administered one dose of prophylac-
tic cloxacillin.13 Injuries to the growth plate are a possible
complication correlated with incorrect placement of the
needle. Fiser et al and Claudet et al performed prospective
studies to evaluate the effect of IO on tibial growth. They
performed radiographic follow-up examinations after IO
treatment, 16.2 months and 29.2 months, respectively, that
showed no tibia discrepancy between the two legs, indicating
no long term effect on tibial growth.14,15 In our case an
experienced paediatric haematologist performed the IO at
the anteromedial surface of the proximal tibia, and future
risks for growth plate injuries should be minimal.
Several studies have demonstrated the value of IO adminis-
tration of emergency medications when establishing an IV ac-
cess is difﬁcult. However, to our knowledge, only one recent
study has demonstrated an IO blood transfusion successfully,
in a 5 month old female with a severe traumatic brain injury.16
That intraosseous blood transfusion was given at a trauma
centre to a younger child with a traumatic haemorrhagic
shock. In our case, the child was given the transfusion at a
smaller mission hospital without access to advanced technol-
ogy such as a battery-powered IO driver, as in the above de-
scribed case.
In summary our patient was admitted unconscious to the
Mission hospital, where the cannulation of both a peripheral
and central vein failed due to vascular circulation collapse.
The primary infusion of Ringer lactate stabilized the circula-
tion, but there was still no possibility to infuse the blood
through the veins. Intraosseous blood transfusion was there-
fore the only option in this very urgent situation. We conclude
that performing an intraosseous blood transfusion should be
the immediate intervention in life-threatening situations like
this one.Conﬂicts of interest
The authors declare no conﬂict of interest.
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